Shows GSK's RSV Vaccine Candidate Provides Protection for Older Adults
The vaccine candidate contains a recombinant subunit prefusion RSV F glycoprotein antigen (RSVPreF3) combined with an adjuvant.
Stay updated with breaking news from Hal Barron. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The vaccine candidate contains a recombinant subunit prefusion RSV F glycoprotein antigen (RSVPreF3) combined with an adjuvant.
A $1,530,000 grant from the Ralph C. Wilson, Jr. Foundation will help pay for the construction of the 6.5-mile Monroe Area Loop Trail.
There is a tendency, particularly in the healthcare and tech sectors, for companies to head to New York and other markets.
The deal to acquire the biotech firm is intended to strengthen GSK’s vaccine R&D and technology offering.
Affinivax is developing a vaccine to combat pneumococcal diseases which include pneumonia and meningitis as well as milder illnesses such as sinusitis.